JP2014024874A5 - - Google Patents

Download PDF

Info

Publication number
JP2014024874A5
JP2014024874A5 JP2013231673A JP2013231673A JP2014024874A5 JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5 JP 2013231673 A JP2013231673 A JP 2013231673A JP 2013231673 A JP2013231673 A JP 2013231673A JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5
Authority
JP
Japan
Prior art keywords
tableting
dissolution
improving
composition
magnesium stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013231673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014024874A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013231673A priority Critical patent/JP2014024874A/ja
Priority claimed from JP2013231673A external-priority patent/JP2014024874A/ja
Publication of JP2014024874A publication Critical patent/JP2014024874A/ja
Publication of JP2014024874A5 publication Critical patent/JP2014024874A5/ja
Pending legal-status Critical Current

Links

JP2013231673A 2006-06-27 2013-11-08 圧縮製剤 Pending JP2014024874A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013231673A JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006176146 2006-06-27
JP2006176146 2006-06-27
JP2013231673A JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008522575A Division JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤

Publications (2)

Publication Number Publication Date
JP2014024874A JP2014024874A (ja) 2014-02-06
JP2014024874A5 true JP2014024874A5 (enExample) 2014-08-07

Family

ID=38845498

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008522575A Active JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤
JP2013231673A Pending JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008522575A Active JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤

Country Status (9)

Country Link
US (1) US20100237530A1 (enExample)
EP (1) EP2033643A4 (enExample)
JP (2) JP5769362B2 (enExample)
KR (1) KR101628028B1 (enExample)
CN (1) CN101478966B (enExample)
BR (1) BRPI0713371A2 (enExample)
CA (1) CA2656181C (enExample)
TW (1) TWI492747B (enExample)
WO (1) WO2008001734A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2510866T3 (es) * 2008-03-13 2014-10-21 Daiichi Sankyo Company, Limited Mejora de la solubilidad de una preparación que contiene olmesartán medoxomilo
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンii受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンii受容体拮抗剤の保存安定性向上方法
CN102119930B (zh) * 2010-07-13 2013-01-30 福建天泉药业股份有限公司 一种奥美沙坦酯片及制备方法
EP2425859A1 (en) 2010-08-08 2012-03-07 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Olmesartan formulations
CN102028663B (zh) * 2010-12-14 2011-11-30 北京万生药业有限责任公司 一种稳定的奥美沙坦酯固体制剂
PT2830618T (pt) * 2012-03-30 2016-11-04 Dae Woong Pharma Composição farmacêutica compreendendo olmesartan medoxomilo e rosuvastatina ou o seu sal
CN105663070A (zh) * 2014-11-21 2016-06-15 深圳信立泰药业股份有限公司 一种含有奥美沙坦酯的药物组合物及其制备方法
CN105640913B (zh) * 2016-01-22 2018-11-02 山东省医学科学院药物研究所 一种奥美沙坦酯片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
JPH0282519A (ja) 1988-09-19 1990-03-23 Sanyo Electric Co Ltd 固相エピタキシャル成長方法
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
CN1185013C (zh) * 1998-07-15 2005-01-19 旭化成株式会社 赋形剂
JP3796562B2 (ja) * 1999-05-26 2006-07-12 ライオン株式会社 多層錠、多層錠の製造方法及び多層錠の剥離抑制方法
KR100496749B1 (ko) * 2000-07-05 2005-06-22 아사히 가세이 가부시키가이샤 셀룰로스 분말
JP2002167327A (ja) * 2000-09-22 2002-06-11 Takeda Chem Ind Ltd 固形製剤
US20040132731A1 (en) * 2002-06-26 2004-07-08 Fox David Nathan Abraham Novel combination
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension
WO2005014043A1 (en) * 2003-07-16 2005-02-17 Boehringer Ingelheim International Gmbh Chlorthalidone combinations
ES2688193T3 (es) * 2003-10-15 2018-10-31 Fuji Chemical Industry Co., Ltd. Comprimido de disgregación rápida en la cavidad oral
GB0325291D0 (en) * 2003-10-29 2003-12-03 Pfizer Ltd Novel combination
CN1874774B (zh) 2003-10-31 2011-04-13 武田药品工业株式会社 包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨醇脂肪酸酯的固体制剂
US20060074117A1 (en) * 2004-09-02 2006-04-06 Lilach Hedvati Purification of olmesartan medoxomil
JP5110697B2 (ja) * 2005-06-27 2012-12-26 第一三共株式会社 固形製剤
TWI407978B (zh) * 2005-06-27 2013-09-11 Sankyo Co 濕粒狀藥物之製備方法
TWI405580B (zh) * 2005-06-27 2013-08-21 Sankyo Co 含有血管收縮素ii接受器拮抗劑及鈣通道阻斷劑之醫藥調配物
EP1891952B1 (en) * 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil

Similar Documents

Publication Publication Date Title
JP2014024874A5 (enExample)
TR201909173T4 (tr) İşlevselleştirilmiş kalsiyum karbonat içeren hızlı parçalanan katı dozaj formundaki formülasyon ve bunun üretim yöntemi.
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
JP2014167026A5 (enExample)
JP2015511635A5 (enExample)
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
IN2014DE03239A (enExample)
AU2014271645B2 (en) Oral cavity patch
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
RU2011107285A (ru) Новый способ
CN103127010A (zh) 一种稳定的坎地沙坦酯片剂组合物
HRP20141134T1 (hr) Kruta farmaceutska formulacija
JP2015129124A5 (enExample)
JP2017520619A5 (enExample)
JP2009091362A5 (enExample)
JP2015129175A5 (enExample)
CN105106963B (zh) 马来酸曲美布汀缓释制剂及其制备方法
JP2009534292A5 (enExample)
CN103860508A (zh) 一种盐酸二甲双胍缓释片及其制备方法
CN102349876A (zh) 一种治疗胃溃疡和十二指肠溃疡的药物及其配制方法
JP2016535762A5 (enExample)
CN103908435B (zh) 一种氟他胺缓释制剂及其制备方法
CN101461815B (zh) 三氟柳药物组合物及其制备方法
CN103860507B (zh) 一种甲磺酸二氢麦角碱缓释片及其制备方法
JP4630614B2 (ja) 速崩壊性固形製剤